CYP2D6 and Bradycardia: In the study by Yang et al. [29] 8 SNPs of CYP2D6 were inspected to understand on timolol-induced lowering of IOP and side effects, i.e. bradycardia, demonstrating that the genotypes Arg296Cys and Ser486Thr did not significantly affect IOP.